Skip to main content
. 2022 Jul 15;22:1359. doi: 10.1186/s12889-022-13631-w

Table 2.

Description of implementation outcomes and measurement for Smokefree Support Study 2.0

Implementation Outcome Description Measurement Data Source Time Point
Acceptability Site staff perceived acceptability of tobacco treatment intervention (e.g., met needs, provided cessation assistance wanted, helpfulness and quality of assistance.) Site staff surveys NCORP Site Staff Baseline (before trial enrollment), 12 months, 24–36 months follow-up
Open-ended questions about aspects of the program most/least helpful, challenges faced to participation, and topic and program recommendations Site staff focus group interviews NCORP Site Staff Following completion of trial enrollment
Patient satisfaction with content/delivery of their randomly assigned tobacco treatment Participant 6-month follow up survey Study participants Patient 6-month follow-up
Program engagement (recruitment video, reasons for enrolling), intervention (counseling components and medication), remote delivery and assessments, tobacco counselor, and oncology team support Post-treatment participant exit interview VIT participants Following completion of patient 6-month follow up survey
Organizational Readiness Site program uptake, Site engagement in implementation facilitation activities

Patient Screening Log

Study administrative data

NCORP Site Staff

MGB research staff

Weekly

Monthly

Appropriateness Perceived fit and relevance of the VIT and EUC interventions from the perspective of representative site staff Site staff surveys NCORP Site Staff Baseline (before trial enrollment),12 months, 24–36 months follow-up
Site staff focus group interviews NCORP Site Staff Following completion of site participant enrollment
Treatment Fidelity Delivery of all components of the Smokefree 2.0 Study Treatment Interventions (EUC and VIT) Tracking of NCI Quitline sessions and NRT dispensed (EUC) NCI Quitline, EUC participants Twice yearly
Collection of data at follow up timepoints regarding whether participants were advised to quit/referred to NCI Quitline by oncology providers EUC participants Patient 3-month and 6-month follow -up surveys
Tracking of number of contacts, session content and completion, NRT dispensed, and any intervention modifications (e.g., counselor adherence to the VIT manual, medication changes) (VIT) MGB research staff, VIT participants Weekly
Cost Incremental cost per quit of the VIT intervention relative to the EUC control over the 6-month follow-up period Tracking of local staff effort (time x base salary) related to eligibility screening, recorded in the Patient Screening Log NCORP Site Staff Weekly
Counseling delivery costs and NRT delivery costs recorded in MGB database MGB research staff Weekly
Feasibility Ease of delivery and suitability for routine care of the VIT and EUC interventions Site staff surveys NCORP Site Staff Baseline (before trial enrollment),12 months, 24–36 months follow-up
Site staff focus group interviews NCORP Site Staff Following completion of site participant enrollment
Penetration/Reach Patient participation rate at each site, reasons for study ineligibility and refusal, comparison of sociodemographic and cancer variable characteristics of enrollees and refusers of the study Patient Screening Log, NCORP Admin data NCORP Site Staff Weekly
Sustainability Resources needed and preference for a site-based centralized tobacco treatment program Site staff surveys NCORP Site Staff Baseline (before trial enrollment),12 months, 24–36 months follow-up
Site staff focus group interviews NCORP Site Staff Following completion of site participant enrollment